Dissection of PIK3CA Aberration for Cervical Adenocarcinoma Outcomes

SIMPLE SUMMARY: There is limited information about genomic markers, especially for cervical adenocarcinoma treatment decisions. In this prospective study, it was found that nonsynonymous PIK3CA mutation detected in the patient’s circulating DNA collected before treatment or during follow-up was sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Tony K. H., Doran, Graeme, Cheung, Tak-Hong, Yim, So-Fan, Yu, Mei-Yung, Worley, Michael J., Elias, Kevin M., Thorner, Aaron R., Pedamallu, Chandra Sekhar, Ojesina, Akinyemi I., Lau, Kei-Man, Ducar, Matthew D., Wong, Raymond R. Y., Wang, Vivian W., Nag, Anwesha, Wollison, Bruce M., Dalgarno, Audrey, Lee, Jacqueline H. S., Yeung, Suet-Ying, Wong, Lo, Horowitz, Neil S., Davis, Michelle R., Leung, Shuk-On A., Mu, Yi, Mok, Samuel C., Chan, Paul K. S., Lawrence, Michael S., Crum, Christopher P., Chiu, Rossa W. K., Berkowitz, Ross S., Wong, Yick-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269188/
https://www.ncbi.nlm.nih.gov/pubmed/34203201
http://dx.doi.org/10.3390/cancers13133218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269188/
https://www.ncbi.nlm.nih.gov/pubmed/34203201
http://dx.doi.org/10.3390/cancers13133218

Ejemplares similares